There WAS no money in Ebola when he made that statement. There also was no epidemic with the potential to be a calamitous worldwide disaster. It was not in the headlines.
But now, there IS a hideous world wide epidemic potential, and there IS grant money available .
The fact that NNVC decided back then to pursue FluCide as their first approved drug was wise, as the potential market for the first ever treatment for viral Flu is in the $5B a year range -- FIVE BILLION PER YEAR. And back then the financial potential for a successful Ebola drug was next to nothing. As fincncial stewards of the company, it would have made no sense to pursue EbolaCide back then over FluCide. Advancing FluCide was the appropriate choice.
To take his statement from years ago out of context and imply it somehow shows the company is only in it for the money is beyond ridiculous. They did the rational, appropriate thing, that everyone who does the least amount of DD understands.
News 
Market Data 
Discover 
AI
